File 3
File 3
File 3
DEPARTMENT OF P IVERSlTY
FACULTY OF PHA~ ~~~A YCY PRACTICE
. . LUCKNOW
RR~E~~~~~~-~~ili·~mvc;;;;t;~J~:~±0-·~-.. :_ ·
I P NO : " I J '· ') ••
ADD: '" IWYJ ft'NI ~
• i11m·,
--
r-- --- -
4 J ,·-;,-r;,;;-:J-:--.
or,", :, -J~~ 1-::_ :k ·-.-,_-
l)(>n, ::,.,'w.:1
D4 D5 D6 D7 D8
VITA LS
BP(m mHg )
PR / Min
RR/M in
0
Temp. ( C)
Fluid Intak e(ml)
Fluid Output(ml}
HEENT
CVS
RS
GIT
GUT
BXT
AL DIAGNOSIS:
R.i hl D;abel-tc Fool--
--,
LADO RA TORY INVE STIG ATIO NS
I HEMA TOLO GY II 2 KIDN EY PANE L I l Lll'ID PROFILE I l D
RBC(M ale> I 4.3-5.9xt<J6tµL Urea 1~7mg /dl !) 6 (;.c, ·101111-C <200 mg/dl 1-/', ,} I
RBC(F em) 3.5-5.0>'108/µl BUN 8-20m!)'dl TGs(F) <150 mg/dl
l
Hct(M ale) 39%-49 % Creatininc 0.6-1.2 mgldl Y, \ I LDL 70-160 mg/di,
3
Hct(Fe m) Uric acid <7 mg/dl IIDL 40 mg/dl 1'1 •1,,
33%-43 %
4
Hb (Male) 14-18 g/dl 13,3 cGFR ~120m Vmln LIVER FUNC TION TEST
Albumi n 3.~.8g/dl AST(SG OT) 0-35 units/I.. I I Ir, 5
Hb{Fe m) 12-16g/dl
Ill,,'->
-
Globulin 2.3-3.5 gldl ALT(SGPT) 0-35 units/I.. 6
MCV 76--100 pm3
Sodium 135-145 mEq/1.. ALP 30-120 unlts/L 7
MCH 27--33 pg
Potassium 3.5-5 mEq/1.. GGT 0-70 units/L
MCHC ~7g/ dl 8
Chlorid e 95-105 mEq/1.. 11Jiirubin-total 0.1-1 mg/dl
ESR (Male) 0-20mmJh
Calciun Hotal 8.5-10.5 mg/dl 131lirubin-chrecl 0-0.2 mg/dl
ESR(F em) 0-30mm!l'l
Alk phosph atase 30-120 U/L CARD IAC 1310J\ 1ARKE RS 10
\-v'BC 4-11 X 103}µl
2.5-4.5 mg/dl CK-MB 5-25 IU/L
Neulro phils 40%-70% Phosph orous DISCH ARGE ~IEDl C ATlON S
22-29 mEq/L cTn! 0 01-0.04ng/mt
Lymph ocytes 20%-40% Bicarb onate l\1cdic incs
Homoc ysteme 4.6-15µmoUL
0%-11% URIN E ANAL YSIS
To"1 . Au_r11 er,-f.fr> c, Q Ei nJ
jMono cytes
Yellow/ amber \' LDB 140-200 U/L
Color
I Eosinophils 0%-8% ,,. , ........,. MISCELLA'NEO'US
BaS()phils 0%-3% Spec. gravity 1.002 to 1.030 I
PLTCo unt 150-45(),c10¥JL pH 4.5-8
,..,., / TSH
.
2-10µ\J /ml
rob. po.n - D uom ~ D
....,f f
T4 ~- '" 5.4-11.5 j,g)dl:
To.b. °7'.e..,""!oc; ot !, ~I
Protein 30 to 130 m!>'day I,
Iron 60-JIO mcpt.
S6 I• P.Lip ~ , 0-160 untts/l. .•
RBCs
~
Sign.of~~
_;.·--l.~i
:~~~i;,_~~,i5:--~---------.-N-T_E_G_R_A_L_U_N_IV_E_R_S_ITV
_
_ c_ uLTY OF PHARM ACY
FA
-""-~
----------✓..-...,-
;.
_ii ;1 ~
1•¥;;.
- - - - - -
~~~,~-
( ,1
- -- - - - - - - - - - - - L UCKNO W \~ ".i.;'f
, ~ f-..i,;,,;,.tf!,
~
~
r~~~~~~~;~~~11
.-\DD :
~~~tJ~ ,W--,,-- - -; (~P~ha~rm.D. Internship)
,, II' .N,O : (),_,(.If llF;.~.--;. .~S,~~J no~ _? ~l t~ /J · ooo:) ff !t.3
R EAS ONS FOR \DI\IIS SI ---- - 1\( ,1·.: ,, 1y (.F~ OF I{ · IY/n/c w~:u;1n- HE l(;IIT -
- - - •
' ,, O N/ Clll t-:F ( 'Ol\11'1\I Nl S(('():
"y
ra,'n rn 1//xlotnN) x I moo/I,,
l' ,\ST VI El>I< ,\I. 11 is-1ORY (PMIIJ:
N()ne
DR l G ( \ 1 E D C \TION ) HISTORY : FA MILY HI STORY: JI ,g
I
S URGI CAL IIISTORY: /\)On(! I
1
L 06.J
I
SOCIAL & OCCUPATIONA L HISTORY:
BP<mmH g)
PR / Min
RR / Min
Temp. (°C) fl I,:
Fluid Intake (ml)
Fluid Output(ml)
HEENT
CVS
RS I
GIT I WNL
GUT
EXT
CNS
Others
•/ \ v
eat:
Im~
~
~ •
-
~
~
.
.
PATIENT NAM£.
. (JIOT!<I/N
INTEGRAL UNIVERSITY
DEPARTMENT OF PHARMACY PRACTICE
FACULTY OF PHARMACY, LUCKNOW.
-
PHYSICAL EXAMINATIONS: .Sl•mo1 i11111: l"onjdou1 / D.-o"'>' /CoauCOIC
'-'
GENERAL EXAMINA1 ION: J>-J-C-C-IA!: Pallor: \ 'rs/lli,o kctnai/Jaundkc: Yrs/ l)o Cyano!ilt1: ,. l'tt {.No
Clubbln;: '\ et /ro l.)ntpl111dtno1>:alh): \ 'l'S / No l':th.-mll: \'t•• /1No
\
VITALS 1>6 ()9 D10 DI I Oil DIJ l>l4 l>l~
IJP (rnmllg)
PR/ Min
RR/ Mm
Temp. (0 C)
Fluid Intake (ml)
flwd Output(rnl)
HEENT
CVS
RS
arr
OUT
8XT
.7 7 J } ) -)
;y , . .. ) )
KlDNE\' PANEL ) ) )
~-3-5.9x10ll,,i.: Urea 2
11 18--47 mg/dL
LIPID PROFILE PATIENT PROGRESS
3.5-5.0x 1()11,t_ 2 I I Day I
BUN Total-C <200 mg/dL
(Male) 39%-49% 8-20 mg/dl
TGs (F)
- 1
Creatinine 0.6-1.2 mg/dl <150 mg/dl
lic:t(Fein) 33%-43% -
Uric acid LDL I 70-16q m~dL 2
Hb(Ma)e) 14-18g.ldl <7 mg/dl -J
eGFR HDL I 40 mg/dL
Hb(Fem) 12-16 gldl. 90-120 mVmln
LIVER FUNCTION TEST
-4
MCV Albumin 3.3-4.8 g/dl
76-100 ,nn3 AST{SGOT) 0-35 unffsll.
MCH Globulin 2.3-3.5 g/dl o I
27-33 ALT(SGPT) 0-35 units/l
Us-
Sodium 135-145 mEq/L 6
MCHC ~7g1dl ALP
Potassium 30-120 unffs/L
ESR(Male) 3.5-5 mEq/L -7
0-20mmlh Chloride GGT I 0-70 unitsll
ESR(Fem) 95-105 mEq/L
0-30mmlh Bilirnbin-total I 0.1-1 mg/dl 8
Calcium-total 8.5-10.5 mg/dl -
WBC 4-11 ><103/µl Bilirubin-direct I 0-0.2 m9idl 9
Alk phosphatase 30-120 U/L -
Neutrophils 40%-70% CARDIAC BIOMARKERS
Phosphorous 2.5-4.5 mg/dl 10 / ,.,
Lymphocytes 20%-40% CK-MB 5-25 TU/L
Bicarbonate 22-29 mEq/L
Monocytes cTnl 0.0 l-0.04ng/mt DISCHARGE MEDICATIOXS
0%-11% URINE ANALYSIS Hojijocysteine 4.6-15 µmo l/L M edicines Dose I RL j frq I Dur
Eosinophils 0%-8% Color Yellow/ amber , - ' ·L 1 1!40-200 U/L
Basopbils 0%-3% ., --1i....:. ,
Spec. gravity 1.002 to 1.030 . ·1....::1 MISCELLANEOUS Jj! r f!'lor;O':,~ 1.Q •. IC'
PLTCount 150-450x11P1p1. I !3.Jo pH 4.5-8 v , I
2-10 µUhnl,'
1ron 160--110 mcg/L Protein 30 to 130 mg/day 5.4-11.5 µgld,l.i
BLOOD GLUCOSE RBCs S6 0-160 lllffs/L,._ ErJ :on 'I~ m3 "i""t•cl Li!--/ ll 6 c~
WBC S5 lnJ -:.ms~.: urriat't-t .. ,,. · -' -··
·~! l}-4ng/ml !?
--g- Neo::itiv..
e
Ims 1--. I I Is.~, Casts i---·--·- I •.,J1 IRAJ1ibToci' •m:sv I I I . 1 r -0
Crystals
PPBS <,....., NI , •" ' . I . .r,f,v /o .!.f. _,i., I ,r,.,. c
"~ J ,,. ....
NI
DIAGNOSIS· C ,;,· FOLLO" UP. <' ,,
' 'j·,
i. r :t ~". ~ I'
MEDICATION CHART
Dose Route 5 6 7 8 , 1 :; = 1 ;:; 1 ;:; 1 :; 1 ;:;;
Generic Name I Indication j II II Freq.
Freq I 1I 2 I 3 I 4 I
\. '-
\.
" '
~
\.
\.
Sign. of Preceptor:
- - . ~
~q - ,
INT EG RA L UNIVERSITY ~~~:,~
PRACTICE
DEPARTMENT OF PHA RM ACY
O~F;P , ~LU~C=K~~~~~-- - - -- --~
;H~A~R~M~A~c:~v:_
!.~~l - ~-) -~ !
.....'ti. ~~'
- -- - - . ~F:A~C~U~L~TY~ :..•011~"'
----
·- -- ~ -- ,_-
-
No fa 1t'llfI'•L\1 •
{!)(/_
(_
1
t' /,'1~•::/09 1
)
SUR GIC AL IIIST ORY : J,.j,'l
/,;1~ ,
I
ORY :
SOC IAL &OC CUP ATI ONA L HIST
\
PERSONAL HABITS: Diet~ /\Jon vf'
Alcohol: Any other:
ADD ICT ION S-D URA TIO N Smo kii:g :
,r ~.
D13 D14 015
D2 D3 D4 D5 D6 , D7_, , os D9 D10 Dll D12
VITALS D1
BP (mrnHg)
PR /Mi n
RR / Min
Temp. (0 C)
Fluid Jntakc (mJ)
Flui d Output(mJ)
HE EN T Nfl/J
CVS
RS
GIT
GUT
EXT
CNS
\ \. .,-- I
i.--.-~-i--.J.__-l---r--i--t-r
-r
'\. _J--.- -r El 1· I I t I IE
Sign. of Preceptor!
. I l
JI
Hz,
Cl'1~ 'b11foholnc\ame
'1
&s
-
_ 1gn. ~f S~d~nt:
I --~-
N
H"'\
1 ,.--..,
INTEGRAL UNIVERSITY
"' DEPARTMENT OF PHARMACY PRACTICE
FA CULTY OF PHARMACY, LUCKNOW .
"I
PATIENT PROFILE FORM~ill.rnt!fl
~
ADD :
Ir N(l: / 3 (, 't OFPTJ l lN IJ : _] UOA, fJ /9 /rJ?, DOD: II 9 ~3
A<:1,, 'I I y , ;.:Nont: f
")
REASONS FO ADl\llSS IO l'i/ CHI EF l 'Ol\1PLAINTS ((T ) :
I Wt,;l(, IIT: IIE IGIIT :
~
Redne~<J one! scur.//in!J ·,u; dayt
--. 7 ~r-'_!__:n iilf...__&c_~k.._ ___'__ .-------------------;
r-;;;=::::--.:--=--~"~u.!..!.n'!.J.
' HIST(?RY OF PRES E T ILI .I\ FS!-. (lll'l) : PAST MEDICAL HI STORY (PMH):
--- pcd,~n/. t1flos al'(/1")('n//~ r1.1e// C rlayr bock
She df!ve/nr ~eclnesr Ond $CJ.,1e//1h~ . <?//('(, No H / o · f 17 rv , D('(J , 7 8
' '""I ..J ~ _/ C
-
......._
DRUG (MEDICATION) IIISTOR, : FAMILY HISTORY :
suRGICAL HISTORY:
f\./1'l
Nt ne
N~ H / O rrJe.('!tca l,~n
-.. SOCIAL & OCCUPATIONAL HISTORY : [.O l,J
-
. . I.,--""
,
~·
VITALS
BP (mmHg) ,,o ~o
D1 D2
-I
D3 D4 D5 D6 ,, D'/ . ·D8 D9 D10 D11 D12 Dl3 DU D15
PR/Min ";J/y j -
RR/Min I~ I -
Temp. ( C) Ill~
0
RS
GIT
GUT
EXT
.
CNS
Others
I
·~
V Iv I <-
0 .,,...- _, \. j L-
l/ 0 0
t. ,
() ~ I \_ \
Cl
.__tcutU#.WWW.
1_1~,
~;:;:::'(M~'."~''
lkttl'~) 33~3%
·~·-•
~;~ _ [l:'.j-
e __,,......
I·· """""'~
, ,,. -1~f::?~: , i[::J;g_tj
..,. .~~ .....
O
: :f=:J.~ l~!;. ~.c~~ -"~
••yv:,
!if" , ._
4
llh M-1(') 14-18
~----- -----..~ ·-t::.-..:JI___ ;,""' "'"j- .'-"-''·-·-· ·- l:.:«>;'.!
·_- .
llh P~111)
- ~ - --f+WUJ- tt},110111~
. ~ - U Ytft Jl lNCTJ()]'lf :rr~r
:xi::.,~~·--..,.'
Ml'\' 70-100 \1 ~ ,~,-,,rm ,, qr !11, ... B.M 1..-hll l\ .
---,-,-.~---
Men u~, __ ~~"!!... _ tM~mcg,i _ , tililfcm:{~~- ~,:· _:3
IIIL'lll' _ 33--31 g/d\._ __ .t••t')_"_!!ln}_ _ 3.5{,mC /\.
ls~'.<•L\)L 0:-~0_n~~ l'hh!_!!,l~ P5-105 l'll~Q1 1- t . ~ ::::::·..:·••ro:" ,, E
BSR Fc111) ~O 01mn1 __ l'ulc1um-1"1nl 85,105 n1t!_
~--- _4•11•10'/111__ _ __ A.!l_1>h1~11ft,!_ ~
N,·111r.11hlls ~ 0% _ _rl~ hnt!'I'!... __ _2_,_5·:!_5~
Lympho~~ l~s 20%-40% llknrhonn1r 22-29 mEq ·
Monoc, t,•s I 0%-11'1!, l ,.,_ " I I llR(NE ANAL\'SIS r.;;.~1·
Eos11101>l11ts I 0%-8% "--
Color Ytllo\t,l 1mt,e,
nnsophils 0%-3%
PITC011111 S~ gravlt)' 1.002 to Ul30
ill 4.5-8
Iron I 60.. l RO mop/I.
l'm1r1n 30to t3Qn,~ '
BLOOD Gl,UCOSE
RRCs ~
FUS 70--99 mg/dl \VB(' S5
PPBS <160mgld. Sugor Negalive
RBS <160 mg/dL C'a.,1s NI
HgbAlc "'4-5.6% Crystnls NI
FINAL DlAGNOSIS:
MEDICATION CHART Ce bl} I ht! .l;o,k
SN I Drug Brand Nnme Generic Name l11dic11tion
D,m I R<>ult I J t-
, C)
-1-~ - +
"'·· · t/1.J
IISSIO'\'/ Cllll•F ( '0~11'1 \INTS (( {)
Q /8 / ,
t
11~•. r1 /l ' Nll · ,~JJ
1,PHlt'H Male
~;
1101\
w~-~r~ :
/ /j
72 IIF.l<,HT ·
ALLERGIES:
oo D5
~ V
BP<mmHg)
PR / Min "1fJ t "ft/I 18- 82- 88 I
RR / Min /Bl- 291- ?9 I Jqj -
Temp. (0 C) IJ!r -
Fluid Intake (ml)
Fluid Output(ml)
HEENT IJIJI
CVS
RS
GIT
GUT
EXT U WNi
CNS No Mun ,r,un SoLJ nd.
Others
) ) ) ) 'I ) ) )
) ) ) )
LABOR.ATORY INVESTIGATION-.: ) )
Qt'.,M_ATOLOGy
) ) ) ) ---- ------------
I - ) ~ ~
, , ) )
(MaJeU4.3-5.9x1()8/µ I 2 tlPm PIIOflU; I 2 tJ
)J •-,
f RBC·-~- · · -rn ncv L _: l 2 ,."
=___ I KlDNEYr,\NEL fo;,LPATIENT PROGRESS
~ ) )
RBC <fem> 3.>5.0•106/µl.
~--- I lrPn •u--.., .,,~,..,~
1A.A7 mn/nl TntoLr• - - --'-"
PATIENT
r.::-- NAMt,;..QXl llf Drv.r
---.k
-
i- M,• · ,1:, Ytor.
t
illll;lil.f'8.Qf1l.t: fQBM (Cl.GBKt l-llPl
<~.NOE1t
7r-
ll' No , JL?.? 1 o n 1.11,N 11 ,.)l,,,.7
,,.,,w/t"
oo A•
w•:m11T1 t, /..r
1,00, t;/it ~ 1
HE1<.1rr,
A t>o, ,.'Jlirt(•(n1av ;:7t
- -
REASO NS FOR ADMI .S/.ION/ ci"ii1 I• CO l\ll 'LAINfS (C T ) :
lr,~/n:U, t tJrr'rf//y /1~r/NnNl,.. {,ri'~'/5
/J,1,1'' .'17 '-"l•'f''C l'f>lt11nr-n '<!6r/r, r ~ PM
S-.T-0-lt_Y_(_ _ H_):_ _ _ _ _ _ _7
- A_S_T_I\_JE
- , . , . _ - - ,P A _L _H_I
- •D_I_C_
"'I IIS! OR\ ' OF P~ESEN T IL LN ESS f HPl):- - - - - - . . q
,'"{ ',,~ /' r,.~, '°h t,'1.rr/ Ct'mflctrnlf_. n/ Iii c r uf!Msg nl:_. NIYTle..
~e l.artd/J r.n l?6'r!&n~n on! .~he r,{r1J/5 romfft:> rnl~;
IJ O . .'r A C ,r 1 - t(tJ
FAMILY HISTOR Y : N /.';
DR UG (M E DICATI ON) IIISTO lff:
SURG:C AL HISTOR Y: ND
None
SOCIAL & OCCUP ATIONA L IIISTOR Y: l3 €."
ALLER GIES: No
I PHYSIC AL EXAJ\fl NAT:ON S: S.:,1:;01·iu111: Comc i~ Drowsy / Comatose
..>
I
lctcrus/ Jaundic e: Yes/ N~ Cvanos is: Yes/ No,..-
.
/ GE\"ER AL EXAJ\H NAT10i\ ': P-I-C-C -L-E: i'allor: Yes/~
Clubbin g: Yes /No L:,·,'llph adenopa thy: Y cs / N_2... Etlema: Yes / No
~
( r r r r -
r r r r 1 2~
LIPI DP~ ILE
r r r (
y JNVESTIGA TIO NS KIDNEY PANEL -
- I 2
___ ;- <200 mg/dl
Total-C::.::_ _
-
LABORATOR - 2 18-47 mgldl TGs (F) ~ mg/dl
-
----W: MATO LOGY _!__ Urea -
_.;:. ..:... --- 70-160 mg/dL
RBC(Male) 4.3-5.9•106/µl.
- BUN
8-20 mgldl
LDL -
-
RBC(Fem)
Hct(Male)
3.5-5 0•106/µl.
39%--49%
- Creatmme
Uncac1d
0.6-1.2 mg/dl
<7 mg/dl
HVL ~mg/ dl
LIVER FUNC.!!.ON TEST
-
33%--43% 90-120 mVmm AST (SGOT) o-35 units/l
Hct(Fem) eGFR
3..3--4.8g/dl 0-35 units/l.
Hb(Male) 14-18 gidl Albumin ALT(SGPT)
12-16g/dl ' 2.3--3.5 g/dl 30-120 units/L
llb(Fem) Globulin ALP
76-100µm 3 135-145 mEq/L 0-70 units/l.
MCV Sodium GGT
0.1-1 mg/dl
27 33 pQ 3.5-5 mEq,'L 9
MCH Po1Js,1um 13ilirubia-total
33-3~ gl._:.. 95-105 mEq1. 0-0.2 mg/dl
MCIIC Ci1l"nc, Bihrubin-dircct 10
::i-2c r:-"1"' l 8.5-10.5 mg/dl CARDIAC HI0'.\1ARKERS
CSR(Ma!e)
0-3~ r:-~.r.1
Calcium-total
DISC HAR GE
MED ICA TIO NS Dur
ESR(Fem/ Al, pl,ospllJtas~ 30-120U/L 5-25 IU/L Rt. Frq
t:~ j,,. ~~ ,,., .. CK-Ml3 Dose
\1.l~C Phosr!1orous 2.5-4.5 mg/dL
cTnl
0.01-0 04ng/ml Medicines
Neutrophils lJ%,--fC~ I Bicarbonate 22-29 mEq/L 4.6-!SµmoUL
I Homocysteme
Lymp~OC)1CS 20~,...(J'.
0%-11~,
URIXE ANALYSIS
LOH 140-200 U/L Jab .(}jlu.rn 500 B!J
MonOC)lCS Yellow/ amber
Eosmopluls Oo/o-8%
Color
Spec gra\1ty 1.002 to 1.030
TSH
MISCELLANEOUS
2 10µ\J/ml
Tat. Tnyplomfl-t> - B!J
0~%
Basophils
PLTCount 150-450i<10'//IL ' ' pH 4.5-8
T4 5.4-11.5 µgldl 'o-L . fome~I-, n - l - ()1,
Protein 30 to 130 mg/day
Iron 60-180mc.g'L
RBCs S6
P. Liplllle 0-1601.11its/L
traA. Refo/01 Fo'hle Sb
BLOOD GLUCOSE 0-4 ng/ml
Sy f · J; t1'f~oloc Jei m I IC
PSA
WBC S5
FBS 7M9mgd1.
Sugar Negative
PPBS <160mg/dl ()/)
Nff RADI OLO GY/ BIOPSY Tab- fl ·to 7
RBS <160mg/ti. Casts
Crystals Ni Oe.r,que,-+ N~ 1 Aq . . . Re~ c~ "(
HgbAlc <4-5.6%
},"req. 7 8 9 o = .-..
Indication Dose Routl'
SN Drug Brand Name
V v ✓
GE"\ERAL EXA..'\tINATIOJ\: P-J-f'-C-L-E: Pallor: Yes /,Jj.,e-- lcterus/Jaundice: Yes/~ Cyanosis: \'es/~
Clubbing: Yes~ Lymphadenopath y: Yes/~ Edema: Yes/~
'r:18 u
-
l PR Min
/ RR ~in ~o
/ Temp (°C) fJ IF
! Fluid Intake (ml)
/
fluid Output(ml)
HEENT
CVS
RS
GIT
G(Jl
EX'f
CNS
Others
I I
PROVJSfONAL DIAGNOSIS:
Chole/il/,/tul~ ?
) ) ) ) ) ) ) ) )
RATORY INVESTIGATIONS ) ) } ) )
Ht:MATOLOGY t 2 ' ) ; ")?'JJ
KIDNEY l'.\NEI. II 12 P,H JENT PROGRESS
4.3-5.9x1()6/µL Urea Lll'JI> l'IWFILE
18-47 mg/dl Day T
3.5-5.0x1()6/µL Total-( · I<200 mg/dl ~- Pro/!.,!'!_~s - _ --=1
BUN 8-20 mg/dl ~ r
Hct(Mate) I 39%-49% Creatinme His(Fi <150mg/dl
0.6-1.2 mg/dl 2
Hct (Fem) I 33%-43% Unc acid
u~•-~~cm
<?m
LOI. 70 160mg.df
Ff/
1
-f-- - - - - --------..../
/
Hb(Male) .,,,
...14-18•~ g/dl I IC(.WR
~~ m~~dl.
I I I
1
j I IDL 40 mg/dl _- - - - - - - - - - - - . . . . ; /
90-120 m11m1n 1 1
Hb(Fem) • , uvi,,n. Ft NcnoN TEsT ~- r
12-16 g/dl B,3'1" Albumm 3.3-4.8 g/dl I\ST(SGOT) ---1
MCV I 0-35 urnts/L fOl' , lJ
7~100µm3 Globulm 2.3-3 5 g/dl '
!\LT (SGPT1 0-35 urnts/L !IS o
MCH 27-33pg Sodium 135-145 mEq/L ALP 30-120 urnts/L
MCHC 3l-37 g/dl Potassium 3.5·5 mEq/L GGT 0-70 urnts/L
ESR (Male) 0-20 mm/h Chloride 95-105 mEq/L Bil1rub11Hotal 01-1 mg/dl
ESR(Fem) 0-30 mm/h Calcium-total 8.5-10.5 mg/dl B1hrub111-d1rec1 I 0-0 2 mg/dl
WBC 4-11 K103/µL Alk phosphatase 30-120 U/L CARDIAC BIOMARKERS 10
Neutrophils 40%-70% Phosphorous 2.5-4.5 mg/dl CK-MB S-25 IUIL
Lymphocytes 20%--40% Bicarbonate 22-29 mEq/L cTnl 0 01-0 04ng/ml
DISCHARGE MEDIC\TJO'iS
Medicines Or,~ Rt. rr 1 . Our
Monocytes 0%-11% URINE ANALYSIS Homocys1e111e j 4.6-1511mollL
Eosinoph1ls 0%--8% Color Yellow/ amber LOH j 140-200 U/L
Spec gravity 1.002 to 1.030 MISCELLANEOUS
T Sornet+rr~ L
Basopllils 0%-3%
150-450•103/µL pH 4.5-8 TSH 2-10µU/ml T, Replet fo~f j;
PLTCount t. 60
Protein 30 lo 130 mg/day T4 5.4-11 .5 µg/dl
Iron 60-180 mcg/L 1
RBCs S6 p Lipase 0-160 urnts/L Sttp Dtfohab ·
BLOOD GLUCOSE
S5 PSA 0-4 ng/ml
70-99 mg/dl WBC
FBS
<160 mg/dl Sugar Negative
PPBS
93 ,o Casts Nil
RBS <160 mg/dl
Crystals Nil
HgbAlc <4-5.6%
FOLLO\.\ l P: _ _ _ __ _ _ __
FINAL DIAGNOSIS:
I -;;
9 ::, - ti-,.,
MEDICATION CHART
..........-, '--
--,-- t ~ -,
........ ) l.. ~-+-+·
<,/
---t- ~--1
+ -or-
t-
r
t
r
-:~ tt1t·t .
_- -+-·,
- t""' · rt- -' ---,
.... . .-·'
t
Sitn- of Prcn•ptor:
\01)
r \SON ,
11t:::-::-::-!
RE
Q.'Z.J' JJmaJL
-'Ul.!JJ1filt '· · .J.,,.,~,,
111L. Lll.L.11.IJu......,,_ - -
111• NO· r-1 '1
,\l,I• tJ(J y
't '"'
(Pharm.D. lntnrnship)
PERSONA L HABITS: --
.-\DDICTJO NS-DlR<\ TION Smoking: ~
ALLERGIE S: None
PHYSICAL EXAMlNA TIONS: Sensorium: Cons . us/ Dmwsy 1 Comatose
HEf:NT }J(J/
CVS I P. I I ,, IPl'li
RS
Gff
GUT
EXT I JIDI\
CNS
Others
.,
.LI
'ORY INVESTIGATIONS ) ) ) ~ -- -
J ) ·"~
OLOGV 11 12 ) j j j j j j J )
KIDNE \' PANEL ) j
CMafe) r4.3-S,9lC1QG/µL 2 I
Urea 1.1r10 Pr<m,,.,..
--- P,\Tl£'VT PROGRESS
RBc (Fem) 3.5-5.0x 100/µL 18-47 mg/dL l_l I2
BUN l otal-C <200 mg/dl ~ay~f - --- P--;:og,-e s-~- ----- .
Hct(Ma le) 8-20 mg/dl
39%-49% 'I Gs fl· 1 l
Creatm1ne <150 mg/dl
l-lct (Fem) 0.6-1.2 mg/dl IO,
33%-43% LDL 70 Ir,o mg,cll
Unc acid <7 mg/dl !- -~
Hb(Ma le) 14-18 g/dl IIDL
eGFR 40 mg/dl
Hb(Fem ) 90-120 ml/mm .J
12-16 g/dl
-Album111 3 3-4.8 g/dl
LIVER FI INCTION HST -L r /f ,. r - .
, . u ,nfl/ ,~ •
MCV 76-100µm3 ASTfSGOT) umts/1.
G-35 umts/1.
G-35
Globulm L,,J-,J
2.3-3.5 ,O 910L
g/dl ALT (SGPT) --- .
-
~MCH ·~~--v.:;.-
I. 21--3 . ;-;;• ALT(SGPT) G-35 umts/1.ts/l I
~135-14
135-145 5mEq/L
mEq/L ALP 3G-120uni
27--33pg Sodium nJ::n/1 •-
ALP
~--
MCHC
··- 33-37
r,i-,_-,-, gi __
-•J• 3G-120 umts/1.
3.5-5 mEq/L GG1
ESR(M ale) 0-20mmn, G-70 units/I.
Chlonde 95-105 mEq/L
ESR(Fe m) B1ltrub111-total 01-1 mg/dl
0-30mm/h Calcium-total 8.5-10.5 mg/dl B1ltrubm-d1rec1 G-0 2 mg/dl
WBC 4-11 x103/µL Alk phosphatase 30-120 U/L C' ARDIAC BIOMARKERS 10
Neutrophils 40%-70% Phosphorous 2.5-4.5 mg/dl
- CK-MB S-25 IU 1L
Lymphocytes 20%-40% Bicarbo nate 122-29 mEq/L cTnl 0 01-0 04ng/ml DISCH..\RG E \.IEDIC.-\ flO'iS
0,..., R, 1
'1l edicines Fr, Ou
Monocytes 0%-11% URINE ANALYSIS 1-Iomocyste111e 4 6-15 µ11101/L
Eosinoph1ls 0%-8% Color Yellow/ amber LDH 140-200 U/L
Basophils 0%-3% Spec gravity 1.002 to 1.030 MISCELLANEOUS ~" 3"
C , ,, -~ ~ Dt{ .)I """' l.J
pH 4.5-8 TSH 2-10 µU/ml
T •4rnr::.,,'i'l'"
PLTCo unt 150-450• 103/µL
Protem 30 to 130 mg/day T4 5.4-11 .5 µg/dl ,, ,..,
T, 7.e,'firxf.,I 1/ " ' "' Cv· w'
Iron 60-180 mcg/L
RBCs :56 p Lipase G-160 urnts/L
BLOO D GLUCOSE
:55 PSA 0-4 ng/ml Co.p Por.-l cf tJcci a C'.,
70-99 mg/dl WBC
FBS
Sugar Negative --
PPBS <160 mg/dl /. nn / C ,.- ' ,v
"' ·""
Nil
RADIOLOGY I BIOPSY
Casts
RBS <160 mg/dl
Crystals Nil
HgbAl c <4-5.6%
fOLLO \\ t'P:._ _ _ _ _ _ _ __
NOSIS [~g/-- fJn -Me bock ;;
5
MEDI CATI ON CHART Route I Freq.
I Dose I Ro I I I 2 I 3 I ~I
Generi c Name
I Indication I.,~ ,. \. I'-
✓ V
Drug Brand Name
\, '.,. \, ,.. \.
\,
\, ',,,
D 1\, /
I
v· \,, \.
.- -r ~1
!....--l-
r _J--.-,
1-f fT~f:f~ +&H f
~i)!II - of Pn:rcp1or:
t"'
INTE GRA L UNIV ERSI TY
FACUL TY OF PHAR MACY
LUCK NOW
0 t-:-::-=- - J' ~'- n2 ~{ 6/.(JJJJl?.JL1$..L!irla, .,,.,, '\,H.IH< ,\l . 111s roR\ cr " 111
1 .t;,
l~t'~< !~\ ! lFPRF1;-1,,·•q· 1~1loi;t!-.scHr11, 1 1
~ • r~ ,.,,f mpta (nr:~ OJ nf. parn
r. --= 'I ' , 'L
!v o HI() 3 u.;-17•u·:1..
.. /Jt'abele$_ Me/1,/u ~ fr!ecltcahM Sl 'RG){'A L HISTO RY :
V I '-
l .. - -'- . . . . - ~r . ·---+---'
-1.--J-- I ' I
; - t- 1
J T,,-+----1
-r 1 1 1
- - -i--+-.J_
~ --+t-i
//"., I /-If L': I
---i-&/,tf,
Sign. o{ l'~t·n•ptor:
(,~~-'
aut• & s ~-·f student:
4!,m•rJj;(!J'g